Constant pain caused by a fall on the left of Ash Basu in agony, so when his doctor suggested he saw a cannabisman, he was intrigued.
The 64-year-old did not have experience with marijuana, recreational or otherwise, but had heard of the power-enhancing power of the herb and wanted to avoid opioids.
He was referred to a cannabis clinic and the doctor with questions. He was not satisfied with what he had heard.
"They did not seem to have too much information," complains Basu, who was among several dozens of elderly people in a recent briefing about medical marijuana in Toronto.
"The problem that I have is no data on the interactions between all the medications that I am taking. I am diabetic, I have a high blood pressure, I have three different allergic medicines. There are many medications that I am."
Basically left the clinic with authorization to buy medical kannaban oil, but two months later he still did not buy it. He does not think he will do it soon.
"I'm really scared … trying it because I do not want reactions and I do not want to fall. It's my biggest concern," says the Mississauga, Ont., Resident.
Cannabis among older people is tall but there are many questions, says the Ontario Long Term Care Association Candace Chartier, CEO of the Ontario Long Term Care Association.
It is a great reason that her group embarked on a six-month pilot program to track and monitor the effects of medical cannabispower between 500 majors in several unions in the long term.
Medicine cannabis is already used by many residents for a variety of diseases, chartier notes, which say that the staff and family members have already announced positive results anecdotally.
"It affects, it's less time needed to take care of the residents … The caretakers that enter, see a difference in the pain," she says.
"We know it works on a small scale, and so we tend to do it more widely."
Chartier says OLTCA will coordinate the program and develop software tools for nurses, pharmacists, doctors and managers along with the Canopy Growth canabis company, which provides the marijuana.
The results will inform guidelines that could take care of the care of the province's installations worldwide: "It will become clinical support so that every home in the province can benefit it," she says.
Meanwhile, a similar six-month study launches on Monday involving the based cannabis company B.C. Tilray, analyzed the effect of medical marijuana during sleep, perception of pain and quality of life in patients over 50 years.
Philippe Lucas, the vice president of global patient research and access, says the study will begin in Sarnia, Ont., And then expand to more clinics in British Columbia and New Brunswick in 2019.
He hopes to sign up to 600 up to 1,000 patients, and the hunger of detailed data on how older people use cannabis and the results is regrettable.
"There was no long-term tracking, successful studies that deal with the effects of medical cannabis with time," said Lucas.
The Tilray-Ontario study is led by a Sarnia-based cannabis specialist. Blake Pearson, who specializes in cannabinoid therapy for elderly people, including those who live in long-term care facilities.
Pearson says that the hemp is not for everyone, but it is estimated that 60 to 70 percent of patients who are trying medical canaby under their care see some type of improvement.
"Often, I can treat a patient with cannabisleo and reduce two to three of their other medications as a result, because it is multimodal," says Pearson.
"So we can deal with pain, anxiety, sleep with one thing, contrary to three or four different medications."
Reducing medicines could not only improve the quality of life for the patient, but the "quality of workplace for the staff" at long-term medical facilities, says Chartier.
"That could potentially reduce the medication management and could almost cut it in half," she notes.
Canopy's first doctor Dr. Mark Ware points out a medical cannabisket tends to focus on child epilepsy and medieval people with chronic pain and spasticity.
"The elderly have not received much attention and it is a good reason to think that they can handle cannabinoids in a different way than younger," says the factor of pain based in Montreal, formerly vice president of a federal task that studied the legalization of marijuana in Canada.
"They may require smaller doses, they can metabolize drugs more slowly."
He saw a great deal of exploitation in long-term care.
"They have very strong spur systems for treatment – for neurocognitive symptoms, for sleep and pains. So they were really used to track the health of their inhabitants."
Basu says he is looking for a long exploration of arms that are objectively evaluating the medical use of cannabis for elderly people, noticing that he is generally skeptical about studies that occupy the private sector. But he welcomes more attention to careless things.
"Everything about education," he says. "I think the industry needs much more."